BlossomHill Therapeutics Inc. (BLSM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for BlossomHill Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$16.46
+4.47% today
Market cap
$501M
Overall quality
50/100
Kronos AI 30-day
+11.9%
7 of 8 simulated paths end higher
BlossomHill Therapeutics Inc. (BLSM) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $501M. It trades at $16.46, up 4.47% today. Its overall quality score is 50 out of 100, ranked against the whole US market. 5 analysts' average target of $35.40 implies +115.1% from today's price. Kronos AI's 30-day forecast is +11.9% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $35.40 |
| Low – high | $30.00 – $40.00 |
| Analysts | 5 |
| Upside to average | +115.1% |
Kronos AI 30-day forecast
| Expected close | $17.63 (+11.9%) |
| Likely range | +1.8% … +36.7% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
| Profitability | 50 |
| Solvency | 56 |
| Growth | 44 |
| Overall | 50 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.